REGENXBIO Inc.RGNXNASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank25
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-145.58M
↓ 63% vs avg
Percentile
P25
Within normal range
Streak
3 yr
Consecutive growthContracting
Average
$-89.11M
Historical baseline
PeriodValueYoY Change
TTM$-145.58M+26.6%
2024$-198.23M+17.2%
2023$-239.46M+2.0%
2022$-244.24M-244.1%
2021$169.54M+275.1%
2020$-96.83M-7.2%
2019$-90.34M-198.1%
2018$92.08M+225.8%
2017$-73.20M-13.0%
2016$-64.80M-